Veerhealth Care stock price jumps after securing ₹1.5 Cr order from New York-based companyVeerhealth Care stock price jumps after securing ₹1.5 Cr order from New York-based company

Introduction

Leading healthcare company has secured ₹1.50 crore export order from a New York based firm for body care products, with execution timeline set at 45 days.

Also Read: JSW Energy completes full acquisition move with remaining 26% stake buy in JMPCL

Share price movement of Veerhealth Care

On April 13, 2026, Veerhealth Care Ltd opened at ₹20.80, up 1.17% from its previous close of ₹20.56. The stock reached a high of ₹21.21 (3.16%) and a low of ₹20.50. By 11:08 AM, it traded at ₹20.70, a 0.68% increase, with a market cap of ₹41.40 crore.

Veerhealth Care Secures Export Order

Veerhealth Care Limited has received an order from a New York-based company for supply of personal care products, valued at $1,60,650, equivalent to approximately ₹1.50 crore.

The order involves supply of body care products under international terms. The contract is classified as an international order and will be executed on FOB Nhava Sheva basis.

The company is required to complete execution of the order within 45 days. The name of the awarding entity has not been disclosed due to confidential terms.

Stock performance of Veerhealth Care for period of 1 week, 6 months, and 1 year

Veerhealth Care Ltd delivered a 1-week return of -1.30%, a 6-month return of 12.5%, and a 1-year return of 43.5%.

Also Read: BSE Ltd gets SEBI approval to launch derivatives on Focused IT Index, stock in focus

Shareholding pattern of Veerhealth Care

Particulars	Dec 2025	Sep 2025	Jun 2025
Promoter	31.50%	31.50%	31.50%
FII	0.00%	0.00%	0.00%
DII	0.00%	0%	0.00%
Public	68.50%	68.50%	68.50%

About Veerhealth Care

Veerhealth Care Ltd (BSE: 511523) is engaged in trading, manufacturing, and marketing of research based ayurvedic medicines since its incorporation in 1992.

Stay Ahead with the Latest Stock Market Updates – Click Here

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.

FAQs